Collin Vu

发表

Efficacy of the investigational mTOR kinase inhibitor MLN0128/INK128 in models of B-cell acute lymphoblastic leukemia

C. Rommel, D. Fruman, M. Lilly, 2013, Leukemia.

Effective and selective targeting of leukemia cells using a TORC1/2 kinase inhibitor

Jing Chen, Marina Konopleva, Yi Liu, 2010, Nature Medicine.

Target of Rapamycin Signaling in Leukemia and Lymphoma

D. Fruman, C. Vu, David A. Fruman, 2010, Clinical Cancer Research.

Differential Involvement of Initiator Caspases in Apoptotic Volume Decrease and Potassium Efflux during Fas- and UV-induced Cell Death*

C. Bortner, J. Cidlowski, C. C. Vu, 2001, The Journal of Biological Chemistry.